Deep Track Capital LP 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:50 am Sale | 2023-12-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | Deep Track Capital LP | 0 0.000% | -4,259,653 (Position Closed) | Filing |
| 2023-02-14 08:40 am Purchase | 2022-12-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | Deep Track Capital LP | 4,259,653 8.240% | 259,653 (+6.49%) | Filing |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | Deep Track Capital LP | 4,000,000 7.810% | 143,537 (+3.72%) | Filing |
| 2021-09-01 4:20 pm Purchase | 2021-08-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | Deep Track Capital LP | 3,856,463 7.530% | 3,856,463 (New Position) | Filing |